Arizona Bioscience News: ASU medical school dean; Native American cervical cancer ; ‘Success breeds success’; Translational research

February 6, 2025

By Jessica Vaile

Renowned innovator named founding dean of new ASU medical school / Phoenix Business Journal

Arizona State University selected decorated and internationally renowned psychiatrist and innovator of neuromodulation technologies, Sarah Hollingsworth “Holly” Lisanby, as founding dean of the ASU School of Medicine and Advanced Medical Engineering.


Study from UA and NAU links vaginal microbiomes to higher cervical cancer rates among Native American women / Arizona Daily Sun

Researchers from the University of Arizona Cancer Center and Northern Arizona University published a study on how vaginal microbiomes could contribute to the higher rates of cervical cancer in Native American women.


‘Success breeds success’: AZ Venture Capital Inc. CEO outlines investing vision / Phoenix Business Journal (Op-ed)

In this Arizona Commerce Authority story, AZ Venture Capital Inc. president and CEO James “Jim” Goulka talks about making a lasting impact on Arizona’s startup ecosystem with a focus on closing funding gaps and improving investment opportunities for Arizona’s founders, including those from underserved communities.


A biotech company will pay tribes for genetic data. This professor hopes it could change the industry / KJZZ

Krystal Tsosie, an assistant professor in ASU’s School of Life Sciences, talks about Variant Bio’s profit-sharing model with partnering scientific communities and how it could impact academic biomedical spaces.


When this NAU professor looks down the microscope, she sees art instead of algae / KJZZ

For Debra Edgerton, an artist and assistant professor in the School of Art at Northern Arizona University, the connection between algae and society seemed innate when she looked at the microorganisms through a microscope.


Flinn Foundation’s Mary O’Reilly on translational research, collaboration, and advancing healthcare solutions / MDM2

Mary O’Reilly, Flinn Foundation vice president, bioscience research programs, talks with the Medical Device Manufacturing Multiplier Consortium about Flinn’s translational research programs and her insights on Arizona’s bioscience research ecosystem, its funding, and innovations in health care.


 Upcoming Events:

Feb. 7-8: 4th Annual Alzheimer’s Disease Symposium
Feb. 11: BIO5 Student Industry Networking Event
Feb. 18: Arizona Rural and Public Health Policy Forum
Feb. 19: AZBio Day at the Capitol
March 6: Flinn Foundation Bio Capital Conference
April 2-3: Venture Madness 2025


Check out our new Bio Blog for the latest news about Arizona’s Bioscience Roadmap.